YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

FDA approves new nasal spray for migraines

Posted online

The Food and Drug Administration gave the green light to a new nasal spray for migraines.

Pfizer's fast-acting treatment will be sold as Zavzpret.

Company officials said the medication would come to pharmacies in July.

Read more from The New York Times.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences